Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

Rwanda is set to become home to Africa’s first manufacturing plant for eye care products and monoclonal antibodies targeting cancer, with completion expected by 2026, according to Dr. Menghis Bairu, ...

DEVASTATED Nadia Sawalha fought back tears in an emotional video as she shared some heartbreaking news. Loose Women star ...

An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.

The company reported a robust set of numbers for the December quarter of FY25, with its profit nearly doubling year-on-year ...

Subcutaneous administration of trastuzumab and pertuzumab significantly shortened the time patients with stage I ...

Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has shown clinically meaningful 'improvement' in the ...

allergies to the drug components in this protocol, history of immunodeficiency diseases, inability to swallow, and pregnancy or lactation. Pyrotinib 400 mg was administrated orally once daily within 6 ...

("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has been successfully dosed in the Phase III clinical study (Study ID: JSKN003-301) of anti-HER2 biparatopic antibody-drug ...

1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. Search for other works by this author on: 1Department of Investigational Cancer ...

Section 5A RTA 1988 - Driving or being in charge with concentration of specified controlled drug above specified limit The offence at section 5A RTA 1988 is driving, attempting to drive or being in ...